e-learning
resources
Milan 2017
Tuesday, 12.09.2017
Rare diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The analysis of alveolar macrophage form in secondary pulmonary alveolar proteinosis complicated with myelodysplastic syndrome.
H. Ishii (Tokyo, Japan)
Source:
International Congress 2017 – Rare diseases
Session:
Rare diseases
Session type:
Thematic Poster
Number:
3852
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
H. Ishii (Tokyo, Japan). The analysis of alveolar macrophage form in secondary pulmonary alveolar proteinosis complicated with myelodysplastic syndrome.. 3852
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Risk factors associated with the development of interstitial lung abnormalities
Rare interstitial lung diseases (LAM, LHC, alveolar proteinosis, eosinophilic pneumonias)
Surfactant protein expression at various COPD Gold stages
Related content which might interest you:
The role of apoptosis in idiopathic pulmonary alveolar proteinosis
Source: Annual Congress 2006 - Usefulness of broncoalveolar lavage (BAL) in interstitial lung diseases
Year: 2006
Our cases with pulmonary alveolar proteinosis
Source: International Congress 2018 – Pitfalls in the diagnosis and management of rare diffuse parenchymal lung diseases (DPLDs)
Year: 2018
Pulmonary alveolar proteinosis
Source: Respipedia Article
Year: 2017
PAS-negative pulmonary alveolar proteinosis
Source: Annual Congress 2008 - Rare clinical cases
Year: 2008
Intercurrent intractable factors in autoimmune pulmonary alveolar proteinosis
Source: Annual Congress 2009 - Various backgrounds in diffuse parenchymal lung disease
Year: 2009
Pulmonary alveolar proteinosis and idiopathic pulmonary hemosiderosis
Source: International Congress 2019 – CCC Airway diseases
Year: 2019
Treatment of severe pulmonary alveolar proteinosis using inhaled GM-CSF
Source: Annual Congress 2010 - Rare diffuse lung diseases
Year: 2010
Rituximab therapy in autoimmune pulmonary alveolar proteinosis
Source: Eur Respir J 2009; 33: 1503-1506
Year: 2009
Reduced GM-CSF autoantibody in improved lung of autoimmune pulmonary alveolar proteinosis
Source: Eur Respir J 2012; 39: 777-780
Year: 2012
Possible ocular involvement in pulmonary alveolar proteinosis
Source: Eur Respir J 2006; 28: 456
Year: 2006
Abnormal intraalveolar accumulation of surfactant proteins in adults with pulmonary alveolar proteinosis
Source: Eur Respir J 2002; 20: Suppl. 38, 90s
Year: 2002
Inhaled GM-CSF for autoimune pulmonary alveolar proteinosis
Source: Short video statement 2020
Year: 2020
Pulmonary alveolar proteinosis
Source: Eur Respir Rev 2011; 20: 98-107
Year: 2011
Pulmonary alveolar proteinosis
Source: Eur Respir Mon; 2009: 46: 208–224
Year: 2009
Lung cysts in pulmonary alveolar proteinosis.
Source: International Congress 2018 – Pitfalls in the diagnosis and management of rare diffuse parenchymal lung diseases (DPLDs)
Year: 2018
Association of pulmonary alveolar proteinosis and fibrosis: patient with GATA2 deficiency
Source: Eur Respir J 2016; 48: 1510-1514
Year: 2016
Peculiarities of pulmonary alveolar proteinosis (PAP) due to exogenous factors
Source: Virtual Congress 2020 – Occupational exposure as a cause of respiratory disease
Year: 2020
Clinical features of secondary pulmonary alveolar proteinosis: pre-mortem cases in Japan
Source: Eur Respir J 2011; 37: 465
Year: 2011
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept